Biotechnology (81) | Change of Control Agreements (81)

Browse by Company

Recent Contracts

Change in Control Severance Agreement dated as of June 1, 2020 between the Registrant and Stacy Coen (IMMUNOGEN INC, Filed With SEC on March 1, 2021)
Severance and Change of Control Agreement, dated February 19, 2021, by and between the Company and Daniel Soland (IDERA PHARMACEUTICALS, INC., Filed With SEC on March 1, 2021)
Amended and Restated Severance and Change in Control Policy (Global Blood Therapeutics, Inc., Filed With SEC on February 24, 2021)
Amended and Restated Change in Control and Severance Agreement, effective (VERACYTE, INC., Filed With SEC on February 22, 2021)
Severance & Change in Control Agreement, by and between the Registrant and Matthew R. Moore (Arcutis Biotherapeutics, Inc., Filed With SEC on February 16, 2021)
Change in Control Agreement dated November 2, 2020 by and between the Registrant and John M. Maraganore (ALNYLAM PHARMACEUTICALS, INC., Filed With SEC on February 11, 2021)
Amarin Corporation plc Executive Severance and Change of Control Plan (AMARIN CORP PLC, Filed With SEC on January 29, 2021)
Change of Control and Severance Agreement, by and between the Registrant and Edward M. Kaye, effective as of October 21, 2020 (Stoke Therapeutics, Inc., Filed With SEC on November 12, 2020)
Change of Control and Severance Agreement, by and between the Registrant and Stephen J. Tulipano, effective as of October 21, 2020 (Stoke Therapeutics, Inc., Filed With SEC on November 12, 2020)
Change of Control and Severance Agreement, by and between the Registrant and Robin Walker, effective as of October 21, 2020 (Stoke Therapeutics, Inc., Filed With SEC on November 12, 2020)